Parameters of the classical complement pathway predict disease severity in hereditary angioedema
Dorottya Csuka1, George Füst, Henriette Farkas
13rd Department of Internal Medicine, Semmelweis University Budapest, Kútvölgyi Str 4, Budapest, Hungary.
Clinical Immunology (Orlando, Fla.)
|February 9, 2011
Summary
Complement C1-inhibitor (C1-inh) and C4 levels can predict hereditary angioedema (HAE-C1-inh) severity. Higher C1rC1sC1-inh and C1-inh levels correlate with more frequent attacks and greater C1-inh concentrate use in HAE-C1-inh patients.
Area of Science:
- Immunology
- Complement System
- Rare Diseases
Background:
- Hereditary angioedema due to deficiency of C1-inhibitor (HAE-C1-inh) is a rare genetic disorder.
- Functional C1-inhibitor (C1-inh) and C4 levels are potential markers for HAE-C1-inh severity.
- Complement activation complexes may play a role in HAE-C1-inh pathogenesis.
Purpose of the Study:
- To investigate the association between disease severity and complement parameters in HAE-C1-inh patients.
- To determine if C1-inh and C4 levels can predict HAE-C1-inh disease severity.
- To explore the role of complement activation in HAE-C1-inh.
Main Methods:
- Studied 105 HAE-C1-inh patients and controls.
- Assessed disease severity by angioedema attack frequency and C1-inh concentrate ampoule (C1-inh-amp) usage.
- Measured C1rC1sC1-inh and C1-inh levels.
Main Results:
- Median C1rC1sC1-inh levels were significantly higher in HAE-C1-inh patients compared to controls (32.8 U/ml vs. 3.4 U/ml; p<0.0001).
- C1rC1sC1-inh and C1-inh levels strongly correlated with attack frequency and C1-inh-amp usage in the entire patient cohort and in those on danazol prophylaxis.
- Both C1rC1sC1-inh and C1-inh demonstrated significant predictive value for disease severity (OR=4.38 for C1rC1sC1-inh, p=0.010; OR=11.78 for C1-inh, p=0.002).
Conclusions:
- C1rC1sC1-inh and C1-inh are suitable predictors of HAE-C1-inh disease severity based on attack frequency and C1-inh-amp usage.
- These complement parameters may serve as sensitive biomarkers for predicting HAE-C1-inh severity.
- Further research is warranted to validate these findings and explore their clinical utility.
Related Concept Videos
01:27Complement System
The complement system is a group of approximately 20 plasma proteins that strengthen the body's defenses against infections through opsonization, inflammation, and cell lysis. Opsonization involves coating pathogens with complement proteins, making them more recognizable and facilitating phagocyte engulfment. Certain complement proteins induce inflammation that attracts immune cells to the site of infection. Cell lysis involves the destruction of pathogens through the formation of a membrane...
01:22Cerebral Edema ll: Pathophysiology
Vasogenic edema is a major form of cerebral edema characterized by abnormal accumulation of fluid in the brain’s extracellular space due to disruption of the blood–brain barrier (BBB). The BBB is a specialized structure composed of endothelial cells connected by tight junctions, supported by astrocytic endfeet and a basement membrane. Under normal conditions, it tightly regulates the movement of ions, proteins, and solutes between the bloodstream and brain parenchyma. When this barrier loses...
01:29Heart Failure II: Pathophysiology
Systolic Heart Failure and Compensatory MechanismsSystolic heart failure (also termed HFrEF, Heart Failure with Reduced Ejection Fraction) is the most prevalent type of heart filure. It results in a decreased volume of blood being pumped from the ventricle. The aortic arch and carotid sinuses have baroreceptors that detect reduced blood pressure, triggering the sympathetic nervous system (SNS) to release epinephrine and norepinephrine. Initially, this response aims to boost heart rate and...
01:21Peripheral Arterial Disease II: Clinical Manifestations and Diagnostic Evaluation
Clinical manifestationsPeripheral Arterial Disease (PAD) manifests through a range of symptoms, from the characteristic intermittent claudication to atypical presentations and severe complications in advanced stages. Intermittent claudication, a hallmark symptom of PAD, presents as exercise-induced muscle pain that typically resolves within minutes of rest. This pain is reproducible and stems from inadequate blood flow, leading to the accumulation of lactic acid produced during anaerobic...
01:19Cerebral Edema l: Introduction
Cerebral edema is a pathological increase in brain water content that disrupts intracranial pressure regulation and impairs neurological function. Because the cranial vault is rigid, even modest increases in tissue volume can compromise cerebral perfusion, distort neural structures, and initiate secondary injury. Cerebral edema develops through four principal mechanisms: vasogenic, cytotoxic, interstitial, and ionic.Vasogenic EdemaVasogenic edema arises from disruption of the blood–brain...
01:29Pharmacogenetic Phenotypes: Alterations in Pharmacokinetics, Drug Targets and Biologic Milieu
Genetic variations significantly influence drug response through pharmacokinetics, receptor interactions, and biologic milieu modifications. Pharmacokinetic alterations impact drug metabolism and clearance, affecting efficacy and toxicity. Variants in drug-metabolizing enzymes, such as CYP2C9 and CYP2C19, alter drug activation and elimination. For example, CYP2C9 loss-of-function variants require lower warfarin doses to prevent excessive bleeding, while CYP2C19 variants reduce clopidogrel...